Growth Metrics

Adaptive Biotechnologies (ADPT) Other Accumulated Expenses (2018 - 2025)

Adaptive Biotechnologies' Other Accumulated Expenses history spans 8 years, with the latest figure at $826000.0 for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses changed 0.48% year-over-year to $826000.0; the TTM value through Dec 2025 reached $826000.0, changed 0.48%, while the annual FY2025 figure was $826000.0, 0.48% changed from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $826000.0 at Adaptive Biotechnologies, roughly flat from $830000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $1.7 million in Q4 2022 and bottomed at $763000.0 in Q4 2023.
  • The 5-year median for Other Accumulated Expenses is $830000.0 (2024), against an average of $1.0 million.
  • The largest annual shift saw Other Accumulated Expenses skyrocketed 58.52% in 2022 before it plummeted 53.9% in 2023.
  • A 5-year view of Other Accumulated Expenses shows it stood at $1.0 million in 2021, then surged by 58.52% to $1.7 million in 2022, then tumbled by 53.9% to $763000.0 in 2023, then rose by 8.78% to $830000.0 in 2024, then decreased by 0.48% to $826000.0 in 2025.
  • Per Business Quant, the three most recent readings for ADPT's Other Accumulated Expenses are $826000.0 (Q4 2025), $830000.0 (Q4 2024), and $763000.0 (Q4 2023).